Immunotech Biopharm Ltd (6978.HK)

HKD 2.47

(8.33%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 846.28 Million 879.43 Million 1.09 Billion 1.21 Billion 416.97 Million 279.21 Million
Total Current Assets 213.89 Million 118.11 Million 412.2 Million 883.72 Million 308.15 Million 185.76 Million
Cash And Short Term Investments 176.97 Million 79.45 Million 353.34 Million 845.38 Million 282.24 Million 174.02 Million
Cash and Cash Equivalents 52.16 Million 58.44 Million 353.34 Million 845.38 Million 282.24 Million 128.33 Million
Short Term Investments 124.81 Million 21.01 Million 163.01 Million 131.83 Million - 45.69 Million
Net Receivables -124.81 Thousand -21.01 Thousand 47.99 Million 34.32 Million - -45.69 Million
Inventory 4.92 Million 7.21 Million 10.86 Million 3.97 Million 4.81 Million 2.29 Million
Other Current Assets 156.8 Thousand 52.45 Thousand -1000.00 34.36 Thousand 21.09 Thousand 9.44 Million
Total Non-Current Assets 632.39 Million 761.32 Million 685.48 Million 326.5 Million 108.82 Million 93.45 Million
Net PPE 500.75 Million 527.25 Million 426.58 Million 154.49 Million 85.35 Million 78.74 Million
Good Will And Intangible Assets 41.88 Million 42.48 Million 14.25 Million 7.37 Million 7.76 Million 2.57 Million
Good Will - - - - - -
Intangible Assets 41.88 Million 42.48 Million 14.25 Million 7.37 Million 7.76 Million 2.57 Million
Long-Term Investments 46.36 Thousand 119.16 Million 163.17 Thousand 131.96 Thousand - -
Tax Assets 89.65 Million -119.16 Million -163.17 Thousand -131.96 Thousand - -
Other Non Current Assets 43.38 Thousand 191.58 Million 244.65 Million 164.64 Million 15.7 Million 12.13 Million
Other Assets - - - - - -
Total Liabilities 675.39 Million 373.06 Million 274.51 Million 81.38 Million 246.63 Million 62.91 Million
Total Current Liabilities 203.43 Million 208.47 Million 180.1 Million 31.61 Million 206.17 Million 19.02 Million
Account Payables 46.76 Million 37.39 Million 32.15 Million 5.84 Million 4.63 Million 752 Thousand
Tax Payables - - - - - -
Short Term Debt 24.67 Million 26.05 Million 20.2 Million 7.2 Million 3.78 Million 2.89 Million
Deferred Revenue 131.84 Million - - 15.03 Million 19.21 Million -2.89 Million
Other Current Liabilities 156.67 Thousand 145.02 Million 127.74 Million 3.53 Million 178.54 Million 18.27 Million
Total Non Current Liabilities 471.95 Million 164.59 Million 94.4 Million 49.76 Million 40.46 Million 43.89 Million
Long-Term Debt 432.49 Million 123.75 Million 90.84 Million 43.85 Million 35.21 Million 30.95 Million
Deferred Revenue Non Current 39.46 Million 40.84 Million 3.56 Million 5.9 Million 5.25 Million 12.93 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 39.46 Thousand -1000.00 -5.8 Million 2.5 Million 1.13 Million 8.11 Million
Other Liabilities - - - - - -
Total Equity 170.89 Million 506.36 Million 823.17 Million 1.12 Billion 170.33 Million 216.29 Million
Stock Holders Equity 173.61 Million 508.43 Million 822.25 Million 1.12 Billion 168.94 Million 214.65 Million
Common Stock 3.57 Million 3.57 Million 3.57 Million 3.57 Million 677 Thousand 69 Thousand
Retained Earnings -1.62 Billion -1.28 Million -965.21 Thousand -610.99 Thousand -171.94 Thousand -63.14 Million
Accumulated other comprehensive income 170.04 Thousand 385.68 Thousand 381.4 Thousand 332.45 Thousand -160.00 -19.56 Million
Common Stock Equity 173.61 Million 508.43 Million 822.25 Million 1.12 Billion 168.94 Million 214.65 Million
Capital Lease Obligation 130.33 Million 148.8 Million 111.05 Million 51.06 Million 39 Million 33.85 Million
Total Investments 46.36 Million 140.17 Million 163.17 Million 131.96 Million - 45.69 Million
Total Debt 457.17 Million 149.8 Million 111.05 Million 51.06 Million 39 Million 33.85 Million
Net Debt 405.01 Million 91.35 Million -242.28 Million -794.32 Million -243.24 Million -94.47 Million

Balance Sheet Charts